DESPARBES ERIC (Chief Financial Officer) received a stock award from BIORA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/17/2023ACC: 0000950170-23-043225
Officer· Chief Financial Officer
Since Jun 2020
+179.63K
Net shares
Net buyer
$125.7K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
219.65K acquired · 40.02K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−40.02K
Price / share
$3.14
Trade value
$125.67K
% of position
40.4%
8/15/2023
99.03K→59.01K
Common Stock
Direct
Shares
+219.65K
Price / share
—
Trade value
—
% of position
372.2%
8/15/2023
59.01K→278.66K
Total
Net shares
+179.63K
Net value
-$125.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/15/2023 | F · Tax Withholding | −40.02K | $3.14 | $125.67K | 40.4% | 99.03K | 59.01K |
| Common Stock Direct | 8/15/2023 | A · Award | +219.65K | — | — | 372.2% | 59.01K | 278.66K |
| Total | +179.63K | -$125.67K | ||||||
Derivative Transactions0
No derivative transactions reported